Public Health Management Corporation   Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2019
NCT03908437
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Public Health Management Corporation

Active Ingredients

Drugs in Phase 4 Trials (2)

buprenorphine (1 trial)

naloxone (narcan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Drug Overdose (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2